Moreover, in breast cancer, anemic patients (Hb< 12.0 g/dl) had a worse local relapse-free survival (LRFS), relapse-free survival (RFS), and overall survival (OS) than those without anemia (Hb≥12.0 g/dl), even exclude the influence of clinical stage[15]. The gene discussed is GSTM1; the disease is breast cancer.